FATAL
发表于 2025-3-30 11:06:51
http://reply.papertrans.cn/32/3153/315214/315214_51.png
Alveolar-Bone
发表于 2025-3-30 15:56:51
http://reply.papertrans.cn/32/3153/315214/315214_52.png
prosthesis
发表于 2025-3-30 16:45:13
http://reply.papertrans.cn/32/3153/315214/315214_53.png
异端
发表于 2025-3-30 22:38:01
http://reply.papertrans.cn/32/3153/315214/315214_54.png
悠然
发表于 2025-3-31 02:02:03
Asha Humbal,Neha Chaudhary,Bhawana Pathakntly, the potentially reduced quality of life, endoscopic therapy represents a favorable approach where appropriate. Endoscopic resection therapies have been successfully applied to selected patients with early tumors of the esophagus with equivalent oncological outcomes. This chapter will address t
Crumple
发表于 2025-3-31 07:11:57
Advances in Global Change Researche two diseases entities should be treated differently. It is clear that chemotherapy or chemoradiotherapy should be given before surgery; however, perioperative systemic regimens have taken over the landscape for patients with EAC in many centers around the world. Although significant regional diffe
Exuberance
发表于 2025-3-31 09:52:14
Mohammed H. I Dore,Peter Simciskodiotherapy (dCRT) is at least equivalent to trimodality therapy in terms of long-term survival for patients with esophageal squamous cell carcinoma (ESCC). Frail patients with ESCC who are not fit for surgery should receive dCRT. For those who are considered fit for esophagectomy, decision between d
色情
发表于 2025-3-31 16:58:09
Kenneth D. Frederick,David C. Majorhe biology and the potential role of identifying biomarkers of response, and offers a comprehensive overview of the clinical trials that have evaluated the use of immunotherapy in different settings of the treatment of esophageal cancer.
Kidnap
发表于 2025-3-31 18:35:32
http://reply.papertrans.cn/32/3153/315214/315214_59.png
Microgram
发表于 2025-4-1 00:13:55
http://reply.papertrans.cn/32/3153/315214/315214_60.png